文献速递细菌感染、耐药与抗菌药物医院感染防控

苏格兰东北部国家4C抗生素管理干预对艰难梭菌感染临床与分子流行病学的影响:非线性时间序列分析

Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
PubMed 文献 · Lancet Infect Dis · 2016-11-04

该研究采用非线性时间序列分析和准实验设计,评估限制4C抗生素(氟喹诺酮类、克林霉素、阿莫西林克拉维酸和头孢菌素)的国家抗生素管理干预及其他感染防控措施对苏格兰东北部艰难梭菌感染临床负担和核糖体分型分布的影响。研究发现4C抗生素使用减少50%与多重耐药流行核糖体R001和R027快速下降相关,医院和社区艰难梭菌感染患病密度分别下降68%和45%,其他干预无显著效果。

要点

  • 限制4C抗生素使用可降低选择压力,减少多重耐药流行核糖体R001和R027。
  • 医院和社区艰难梭菌感染患病密度分别下降68%和45%。
  • 其他感染防控干预未显示显著效果。

核心结论

  • 限制人群4C抗生素使用降低了有利于多重耐药流行核糖体的选择压力,并与苏格兰东北部艰难梭菌感染总负担大幅下降相关。
  • 控制艰难梭菌的抗生素管理努力应考虑核糖体分布和非线性效应。

研究设计与样本

  • 非线性时间序列分析与准实验研究,探索艰难梭菌感染临床负担和核糖体分布的生态决定因素。
  • 研究人群为注册于社区初级保健机构的成人(≥16岁,平均455 508名居民)或收治于三级、地区综合或老年医院的成人(每月平均33 049例总入院)。
  • 2009年5月1日在所有人群中启动混合说服-限制性4C抗生素管理干预。
  • 考虑的其他人群特异性干预包括限制大环内酯类处方指征、引入含醇手消毒剂、全国手卫生运动、全国医院环境清洁审计与检查、提醒减少不适当质子泵抑制剂使用。
  • 主要结局为医院每1000占用床日或社区每100 000居民日的艰难梭菌感染患病密度。

主要发现

  • 1997年1月1日至2012年12月31日,研究医院1 289 929例入院中识别出4885例医院起病艰难梭菌感染,社区455 508名注册成人中识别出1625例社区起病艰难梭菌感染。
  • 4C使用下降预测多重耐药核糖体R001和R027快速下降。
  • 医院起病艰难梭菌感染患病密度与氟喹诺酮类、第三代头孢菌素、大环内酯类和碳青霉烯类使用相关,超过医院人群特异性总使用阈值。
  • 社区起病艰难梭菌感染患病密度由近期医院艰难梭菌感染率、对65岁以上个体引入强制监测以及初级病例氟喹诺酮类和克林霉素使用超过总使用阈值预测。

临床怎么用

  • 通过抗生素管理限制4C抗生素使用可作为控制艰难梭菌感染的综合策略之一。
  • 应监测核糖体分布以评估多重耐药流行株的选择压力。
  • 干预效果评估需考虑非线性效应和人群特异性使用阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whereas many antibiotics increase risk of Clostridium difficile infection through dysbiosis, epidemic C difficile ribotypes characterised by multidrug resistance might depend on antibiotic selection pressures arising from population use of specific drugs. We examined the effect of a national antibiotic stewardship intervention limiting the use of 4C antibiotics (fluoroquinolones, clindamycin, co-amoxiclav, and cephalosporins) and other infection prevention and control strategies on the clinical and molecular epidemiology of C difficile infections in northeast Scotland. METHODS: We did a non-linear time-series analysis and quasi-experimental study to explore ecological determinants of clinical burdens from C difficile infections and ribotype distributions in a health board serving 11% of the Scottish population. Study populations were adults (aged ≥16 years) registered with primary carer providers in the community (mean 455 508 inhabitants) or admitted to tertiary level, district general, or geriatric hospitals (mean 33 049 total admissions per month). A mixed persuasive-restrictive 4C antibiotic stewardship intervention was initiated in all populations on May 1, 2009. Other population-specific interventions considered included limiting indications for macrolide prescriptions, introduction of alcohol-based hand sanitiser, a national hand-hygiene campaign, national auditing and inspections of hospital environment cleanliness, and reminders to reduce inappropriate use of proton-pump inhibitors. The total effect of interventions was defined as the difference between observations and projected scenarios without intervention. Primary outcomes were prevalence density of C difficile infection per 1000 occupied bed-days in hospitals or per 100 000 inhabitant-days in the community. FINDINGS: Between Jan 1, 1997, and Dec 31, 2012, we identified 4885 cases of hospital-onset C difficile infection among 1 289 929 admissions to study hospitals, and a further 1625 cases of community-onset C difficile infection among 455 508 adults registered in primary care. Use of 4C antibiotics was reduced by 50% in both hospitals (mean reduction 193 defined daily doses per 1000 occupied bed-days, 95% CI 45-328, p=0·008) and the community (1·85 defined daily doses per 1000 inhabitant-days, 95% CI 0·23-3·48, p=0·025) during antibiotic stewardship. Falling 4C use predicted rapid declines in multidrug-resistant ribotypes R001 and R027. Hospital-onset C difficile infection prevalence densities were associated with fluoroquinolone, third-generation cephalosporin, macrolides, and carbapenem use, exceeding hospital population specific total use thresholds. Community-onset C difficile infection prevalence density was predicted by recent hospital C difficile infection rates, introduction of mandatory surveillance in individuals older than 65 years, and primary-case use of fluoroquinolones and clindamycin exceeding total use thresholds. Compared with predictions without intervention, C difficile infection prevalence density fell by 68% (mean reduction 1·01 per 1000 occupied bed-days, 0·27-1·76, p=0·008) in hospitals and 45% (0·083, 0·045-0·121 cases per 100 000 inhabitant-days, p<0·0001) in the community, during antibiotic stewardship. We identified no significant effects from other interventions. INTERPRETATION: Limiting population use of 4C antibiotics reduced selective pressures favouring multidrug-resistant epidemic ribotypes and was associated with substantial declines in total C difficile infections in northeast Scotland. Efforts to control C difficile through antibiotic stewardship should account for ribotype distributions and non-linear effects. FUNDING: NHS Grampian Microbiology Endowment Fund.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lawes T, Lopez-Lozano JM, Nebot CA, et al. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lancet Infect Dis. 2016. PMID: 27825595. doi:10.1016/S1473-3099(16)30397-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。